Institutional Ownership
Pmv Pharmaceuticals Inc
CUSIP 69353Y103COMPMVPQ1 2026
13D / 13G Filings
66
Schedule 13D/13G on record
Beneficial Filers
20
Distinct reporting persons
Largest Stake
14.7%
Max % of class reported
Institutional Holders
66
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
66 filings · latest Mar 4, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Mar 4, 2026 | Orbimed Advisors LLC | 13D/A | — | — | SEC |
| 2 | Feb 17, 2026 | Arrowmark Colorado Holdings, LLC | 13G/A | 5.8% | 3.09M | SEC |
| 3 | Feb 9, 2026 | Bml Investment Partners, L.P. | 13G/A | 9.9% | 5.29M | SEC |
| 4 | Nov 12, 2025 | Sio Capital Management, LLC | 13G/A | 5.0% | 2.64M | SEC |
| 5 | Oct 27, 2025 | Orbimed Advisors LLC | 13D/A | 9.4% | — | SEC |
| 6 | Sep 23, 2025 | Tang Capital Management, LLC | 13G | 8.9% | 4.72M | SEC |
| 7 | Aug 14, 2025 | Pfm Health Sciences, LP | 13G/A | — | — | SEC |
| 8 | Aug 13, 2025 | Sio Capital Management, LLC | 13G/A | 7.2% | 3.74M | SEC |
| 9 | May 15, 2025 | Pfm Health Sciences, LP | 13G/A | 6.4% | 3.30M | SEC |
| 10 | Apr 8, 2025 | Sio Capital Management, LLC | 13G | 7.2% | 3.74M | SEC |
56 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Pmv Pharmaceuticals Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Bml Capital Management, LLC | 5.32M | $6.60M |
| 2 | Tang Capital Management LLC | 4.25M | $5.26M |
| 3 | Sio Capital Management, LLC | 3.08M | $3.81M |
| 4 | Arrowmark Colorado Holdings LLC | 2.87M | $3.56M |
| 5 | Euclidean Capital LLC | 2.63M | $3.26M |
| 6 | Eversept Partners, LP | 2.35M | $2.91M |
| 7 | Two Sigma Investments, LP | 1.88M | $2.34M |
| 8 | Adage Capital Partners Gp, L.L.C. | 1.86M | $2.31M |
| 9 | Blackrock, Inc. | 874.4K | $1.08M |
| 10 | Morgan Stanley | 864.3K | $1.07M |